Sulfonylureas, If Used Quickly, Appear to Reverse Neonatal Diabetes

Usually infants born with neonatal diabetes are treated with insulin, which addresses the problem of insulin deficiency, but does not treat its underlying cause.

Feb 25, 2009

A report in the February 4, 2009, issue of Cell Metabolism says that babies born with neonatal diabetes might be able to avoid irreversible damage to the pancreas if doctors treat them quickly with sulfonylureas rather than insulin.

In neonatal diabetes, an inherited condition, there is a defect in the pancreas's potassium channels, which fail to close as they should in response to glucose. The resultant spike in blood sugar damages the pancreas's insulin-producing beta cells, often leading to permanent damage. 

Researchers at the Washington University School of Medicine in St. Louis and the University of Cologne in Germany found that in laboratory mice bred to have "overactive" potassium channels, the injection of sulfonylureas blocked the opened channels, allowing the pancreas to return to a healthy state.

Usually infants born with neonatal diabetes are treated with insulin, which addresses the problem of insulin deficiency, but does not treat its underlying cause. The results of the study suggest that doctors could soon have a treatment tool that reverses rather than merely mitigates neonatal diabetes.  

Sulfonylureas are familiar to most type 2 patients with diabetes because they are typically the second drugs that doctors prescribe, in a sequence that leads from metformin through the sulfonylureas to such drugs as the TZD pioglitazone (Actos), the DPP-4 inhibitor sitagliptin phosphate (Januvia), or the GLP-1 incretin exenatide (Byetta).   

Click Here To View Or Post Comments

Categories: Blood Sugar, Childbirth, Diabetes, Diabetes, Insulin, Kids & Teens, Medications Research, Type 2 Issues


Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Latest
Popular
Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...


Comments


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...


Username: Password:
Comment:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.